Hosted on MSN1mon
Shield Therapeutics awards CEO share optionsLONDON - Shield Therapeutics (LON ... with the options exercisable at a price of 3.7 pence per share. This grant of options is an initial notification for Lundstrom, and the company has disclosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results